Daniel Clark
Stock Analyst at Leerink Partners
(3.35)
# 2,392
Out of 5,022 analysts
50
Total ratings
58.3%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health | Reiterated: Buy | $30 → $34 | $22.09 | +53.92% | 15 | Oct 1, 2026 | |
| ZTS Zoetis | Reiterated: Hold | n/a | $69.49 | - | 13 | Oct 1, 2026 | |
| AMRX Amneal Pharmaceuticals | Reiterated: Buy | $23 | $20.44 | +12.52% | 2 | Sep 17, 2026 | |
| ANIP ANI Pharmaceuticals | Initiated Coverage: Buy | $104 | $72.95 | +42.56% | 1 | Sep 9, 2026 | |
| BLCO Bausch + Lomb | Initiated Coverage: Buy | $24 | $16.89 | +42.10% | 1 | Sep 9, 2026 | |
| COLL Collegium Pharmaceutical | Initiated Coverage: Buy | $45 | $22.04 | +104.17% | 1 | Sep 9, 2026 | |
| HROW Harrow | Initiated Coverage: Buy | $45 | $30.57 | +47.23% | 1 | Sep 9, 2026 | |
| PCRX Pacira BioSciences | Initiated Coverage: Hold | $28 | $24.87 | +12.61% | 1 | Sep 9, 2026 | |
| PHAT Phathom Pharmaceuticals | Initiated Coverage: Hold | $10 | $7.14 | +40.06% | 1 | Sep 9, 2026 | |
| VTRS Viatris | Initiated Coverage: Buy | $20 | $17.55 | +13.96% | 1 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $745 → $785 | $517.26 | +51.76% | 13 | Nov 3, 2025 |
Elanco Animal Health
Oct 1, 2026
Reiterated: Buy
Price Target: $30 → $34
Current: $22.09
Upside: +53.92%
Zoetis
Oct 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $69.49
Upside: -
Amneal Pharmaceuticals
Sep 17, 2026
Reiterated: Buy
Price Target: $23
Current: $20.44
Upside: +12.52%
ANI Pharmaceuticals
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $104
Current: $72.95
Upside: +42.56%
Bausch + Lomb
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $16.89
Upside: +42.10%
Collegium Pharmaceutical
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $22.04
Upside: +104.17%
Harrow
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $30.57
Upside: +47.23%
Pacira BioSciences
Sep 9, 2026
Initiated Coverage: Hold
Price Target: $28
Current: $24.87
Upside: +12.61%
Phathom Pharmaceuticals
Sep 9, 2026
Initiated Coverage: Hold
Price Target: $10
Current: $7.14
Upside: +40.06%
Viatris
Sep 9, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $17.55
Upside: +13.96%
Nov 3, 2025
Reiterated: Buy
Price Target: $745 → $785
Current: $517.26
Upside: +51.76%